Trends - Oxford University - Business Recorder

Oxford University

Delayed doses of AstraZeneca jab boost immunity: study

"There is an excellent response to a second dose, even after a 10-month delay from the first."

Published 28 Jun, 2021 04:54pm

World

Astrazeneca COVID-19 vaccine effective against variants found in India

The study by Oxford University investigated the ability of monoclonal antibodies in Sera from recovered people and from vaccinated people to neutralize the Delta and Kappa variants, the statement said.

Published 22 Jun, 2021 11:51pm

World

Study shows AstraZeneca vaccine works well as third booster: FT

An upcoming study by Oxford University showed that a third dose of the vaccine boosted antibodies to the coronavirus spike protein among participants, it added.

Published 19 May, 2021 12:49pm

World

UK confident vaccines protect against Indian variant

LONDON: Britain is confident that existing vaccines will provide protection from a more transmissible Indian...

Updated 17 May, 2021 10:03am

Pakistan

GCU Press begins publishing research journals

LAHORE: The Government College University Press has started publishing academic journals and other university...

Published 13 May, 2021 03:10am

World

AstraZeneca says COVID-19 vaccine 76pc effective in new analysis, to seek U.S. approval

AstraZeneca also reiterated that the shot, developed with Oxford University, was 100pc effective against severe or critical forms of the disease.

Updated 26 Mar, 2021 12:04am

World

Key insights from US trial data on AstraZeneca's COVID-19 vaccine

The trial results, primarily generated in the United States but also in Chile and Peru, included a 79% efficacy in preventing symptomatic COVID-19, and showed no increased risk of a rare form of blood clots that has caused concern in parts of Europe.
Britain's Medicines and Healthcare products Regulatory Agency concluded at the time that a 12-week gap between doses was the key to achieving the highest efficacy, of around 80%.

Published 22 Mar, 2021 06:19pm

World

EU regulator 'convinced' AstraZeneca jab benefits outweigh risks

The suspensions have provoked intense debate over whether it was prudent to put AstraZeneca inoculations on hold just as vaccination campaigns were beginning to gather pace.

Published 17 Mar, 2021 10:10am

Malala signs Apple TV deal

ISLAMABAD: Pakistani activist Malala Yousafzai, who won the Nobel Peace Prize as a teenager after surviving a ...

Updated 10 Mar, 2021 09:48am

Pakistan

Pakistani Nobel laureate Malala Yousafzai signs Apple TV deal

Yousafzai was awarded the Nobel Peace Prize as a 17-year-old in 2014, sharing the award with Kailash Satyarthi, a children's rights activist from India.

Published 09 Mar, 2021 11:28am

Business & Finance

Covid vaccine maker AstraZeneca doubles 2020 profit

Profit after tax, equivalent to 2.64 billion euros, soared 139 percent compared with 2019, the pharmaceutical giant said in a statement.

Published 11 Feb, 2021 05:01pm

Pakistan

Virtual seminar ‘Reality or myth of Covid-19 vaccine’ held at ZU

KARACHI: “DRAP has approved three vaccines till now. The first is Sinopharm vaccine, second is research project of...

Published 11 Feb, 2021 04:34am

World

What you need to know about the coronavirus right now

Two new variants found in England under investigation.

Published 10 Feb, 2021 10:54am

Govt approves Russia’s Sputnik V vaccine for emergency use

ISLAMABAD: Russia's Sputnik V has become the third Covid-19 vaccine to be approved by Pakistan for emergency use...

Updated 10 Feb, 2021 09:39am

Business & Finance

South Africa looks to J&J vaccine after disappointing AstraZeneca data

S.Africa received 1 mln AstraZeneca doses last week.
Had hoped to start vaccinating health workers soon.
But trial shows reduced efficacy vs virus variant.
Implications for continent as variant has spread.

Published 08 Feb, 2021 08:24pm

Pfizer withdraws application for emergency use of Covid-19 vaccine in India

NEW DELHI: Pfizer Inc has withdrawn an application for emergency-use authorization of its COVID-19 vaccine in India...

Published 06 Feb, 2021 04:06am

World

UK regulators say extra AstraZeneca vaccine data highlights efficacy in elderly

Britain has been rolling out the shot among all age groups after the Medicines and Healthcare products Regulatory Agency (MHRA) was the first regulator to approve it in December.
Nevertheless, there was no evidence there, suggesting that those people over 65 were not getting evidence of efficacy.

Published 05 Feb, 2021 06:21pm

World

Pfizer withdraws application for emergency use of its COVID-19 vaccine in India

Indian health officials say they generally ask for so-called bridging trials to determine if a vaccine is safe and generates an immune response in its citizens whose genetic makeup can be different from people in Western nations.

Published 05 Feb, 2021 11:01am

Business & Finance

COVAX following EMA, Britain, on ages for Astrazeneca vaccine

The COVID-19 vaccine developed by Oxford University and AstraZeneca gives good immune responses in older people.
The EMA has actually not restricted this vaccine in terms of age based upon the entire data packages, and of course that is a stringent regulatory authority.

Published 03 Feb, 2021 07:31pm

World

Oxford says COVID-19 vaccine 76pc effective for 3 months after one shot

AstraZeneca has welcomed the move, saying flexibility to extend the time between doses is the best strategy for the shot.

Published 02 Feb, 2021 11:31pm

World

Elderly in Poland won't be given AstraZeneca shot

If we are talking about the decision of the medical council, we expect it in the coming days or possibly hours, but it is clear that elderly people will not be vaccinated with this shot.
"We are waiting for a clear recommendation from the medical council and then... we will take a decision."

Published 01 Feb, 2021 08:00pm

Business & Finance

EU urges AstraZeneca to speed up vaccine deliveries amid 'supply shock'

EU to require pre-registration of COVID vaccine exports –source.
AstraZeneca asked for further clarification after sudden cut.
EU paid 336 mln euros to boost Astra's production capacity.
Australia, Thailand say Astra has told them of cut to supplies.

Published 25 Jan, 2021 08:44pm

World

EU seeks answers from AstraZeneca on cut to vaccine supplies in Monday meeting

Earlier in January, Pfizer, which is currently the largest supplier of COVID-19 vaccines to the EU, announced delays of nearly a month to its shipments, but hours later revised this to say the delays would last only a week.

Published 25 Jan, 2021 03:12pm

World

Fire at world's biggest vaccine maker in India: local media

Serum Institute is producing millions of doses of the Covishield coronavirus vaccine developed by AstraZeneca and Oxford University.

Published 21 Jan, 2021 05:22pm

World

£100m donated to Oxford University for antibiotic resistance research

On Tuesday, Oxford University received a donation of £100 million ($136 million) to research growing resistance to antibiotics.
The donation, contributed by British multinational chemicals production company Ineos, is one of the largest donations given to Oxford University in its long history.

Published 19 Jan, 2021 07:11pm

Business & Finance

India's Jindal Steel in talks to get COVID-19 vaccines for employees

Will try to get these doses after completion of all frontline COVID warriors' vaccination.
India is currently using Britain's Oxford University/AstraZeneca vaccine, which is also being produced in India.

Published 18 Jan, 2021 05:45pm

World

AstraZeneca files for EU vaccine approval

The EMA said its assessment would "proceed under an accelerated timeline".

Published 12 Jan, 2021 05:32pm

World

More than 1.3 million people vaccinated against COVID-19 in UK, says Johnson

Johnson said more than 1.3 million people had been vaccinated as of Tuesday afternoon, adding that nearly 1,000 vaccination sites would be ready by the end of the week.

Published 06 Jan, 2021 12:21am

World

Vietnam says to buy AstraZeneca vaccine, in talks with other producers

Vietnam, which has yet to give formal regulatory approval to any vaccine, is also developing vaccines domestically.

Published 05 Jan, 2021 09:25am

Markets

Indian shares retreat from record highs; financial stocks, Reliance fall

The country's drug regulator on Sunday gave emergency use approval to two coronavirus vaccines - one developed by AstraZeneca and Oxford University and the other by local company Bharat Biotech.

Published 05 Jan, 2021 09:15am

Gainers
Losers
Leaders

Stock	Price
786 Investments / Oct 16 786 Investments Limited(786)	7.12 ▼ 0.00 (0.00%)
AL- Abbas / Oct 16 Al-Abbas Sugar Mills Limited(AABS)	282.01 ▼ 0.00 (0.00%)
Agro Allianz / Oct 16 Agro Allianz limited(AAL)	11.10 ▼ 0.00 (0.00%)
AL-Abid Silk / Oct 16 Al-Abid Silk Mills Limited(AASM)	3.49 ▼ 0.00 (0.00%)
Ali Asghar / Oct 16 Ali Asghar Textile Mills Limited(AATM)	2.07 ▼ 0.00 (0.00%)
Allied Bank / Oct 16 Allied Bank Limited(ABL)	78.15 ▼ 0.00 (0.00%)
Abbott Lab. / Oct 16 Abbott Laboratories (Pakistan) Limited(ABOT)	780.00 ▼ 0.00 (0.00%)
Abson Ind. / Oct 16 Abson Industries Limited(ABSON)	2.50 ▼ 0.00 (0.00%)
Attock Cement / Oct 16 Attock Cement Pakistan Limited(ACPL)	137.00 ▼ 0.00 (0.00%)
Adam Sugar / Oct 16 Adam Sugar Mills Limited(ADAMS)	31.24 ▼ 0.00 (0.00%)

Stock	Price
786 Investments / Oct 16 786 Investments Limited(786)	7.12 ▼ 0.00 (0.00%)
AL- Abbas / Oct 16 Al-Abbas Sugar Mills Limited(AABS)	282.01 ▼ 0.00 (0.00%)
Agro Allianz / Oct 16 Agro Allianz limited(AAL)	11.10 ▼ 0.00 (0.00%)
AL-Abid Silk / Oct 16 Al-Abid Silk Mills Limited(AASM)	3.49 ▼ 0.00 (0.00%)
Ali Asghar / Oct 16 Ali Asghar Textile Mills Limited(AATM)	2.07 ▼ 0.00 (0.00%)
Allied Bank / Oct 16 Allied Bank Limited(ABL)	78.15 ▼ 0.00 (0.00%)
Abbott Lab. / Oct 16 Abbott Laboratories (Pakistan) Limited(ABOT)	780.00 ▼ 0.00 (0.00%)
Abson Ind. / Oct 16 Abson Industries Limited(ABSON)	2.50 ▼ 0.00 (0.00%)
Attock Cement / Oct 16 Attock Cement Pakistan Limited(ACPL)	137.00 ▼ 0.00 (0.00%)
Adam Sugar / Oct 16 Adam Sugar Mills Limited(ADAMS)	31.24 ▼ 0.00 (0.00%)

Stock	Volume

Markets →

Forex
World
Commodity

Currency	Rate
USD PKR Interbank Selling / Oct 16	171.25
USD PKR Interbank Buying / Oct 16	171.15
USD to Japanese Yen / Oct 16	114.22
USD to Swiss Franc / Oct 16	0.92
Pound Sterling to USD / Oct 16	1.38
Euro to USD / Oct 16	1.16
UK LIBOR % / Oct 16	0.07

Stock	Volume
S&P 500 / Oct 16	4471.37
India Sensex / Oct 16	61305.95
Tokyo Nikkei / Oct 16	29068.63
Nasdaq / Oct 16	14897.34
Hang Seng / Oct 16	25330.96
FTSE 100 / Oct 16	7234.03
Dow Jones / Oct 16	35294.76
Germany DAX 30 / Oct 16	15587.36
France CAC40 / Oct 16	6727.52

Item	Value
Crude Oil / Oct 16	82.28
Karachi Cotton Assoc. / Oct 16	14280.00
Gold 10 Grams / Oct 16	98600.00
Gold Spot / Oct 16	1767.62
Cotton / Oct 16	107.33

Oxford University

Most Popular Articles